This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Katayama, T. Articles by Yano, K. Search for Related Content PubMed PubMed Citation Articles by Katayama, T. Articles by Yano, K. Social Bookmarking                   What's this?

Relationship Between Adrenomedullin and Left-Ventricular Systolic Function and Mortality in Acute Myocardial Infarction

Department of Cardiology, Nagasaki Citizens Hospital, Nagasaki, snowman-kt{at}syd.odn.ne.jp

Hiroshi Nakashima, MD

Department of Cardiology, Nagasaki Citizens Hospital, Nagasaki

Yukiharu Honda, MD

Department of Cardiology, Nagasaki Citizens Hospital, Nagasaki

Shin Suzuki, MD

Department of Cardiology, Nagasaki Citizens Hospital, Nagasaki

Katsusuke Yano, MD

Third Department of Internal Medicine, Nagasaki University Hospital, Nagasaki, Japan

The purpose of this study was to investigate the relationship between plasma adrenomedullin concentration levels and left-ventricular systolic function in patients with acute myocardial infarction (AMI), and to assess whether these findings can be used to predict clinical outcomes, including mortality. One hundred twenty-four consecutive first AMI attack subjects were successfully reperfused with primary percutaneous coronary intervention therapy. Plasma adrenomedullin concentrations were evaluated at 24 hours from onset. Left ventriculograms of all patients taken in the acute (soon after reperfusion therapy) and subacute (21 ±9 days after onset) phases were used to evaluate left-ventricular ejection fraction (LVEF), and the difference in LVEF (delta-LVEF) between the two stages calculated. There were significantly more patients with cardiogenic shock in the H-Adm group (above the median value of plasma adrenomedullin concentrations 3.5 Fmol/mL) than in the L-Adm (<3.5 Fmol/mL) group (p<0.0001). There was significantly higher mortality in the H-Adm group (p<0.01). Multivariate analysis identified plasma adrenomedullin concentrations alone as an independent predictor of mortality (p<0.05). There were no significant differences in acute-stage LVEF between the groups. LVEF in the subacute stage was, however, significantly lower in the H-Adm group than in the L-Adm group (52 ±12% vs 59 ±11%, p<0.05). Also, delta-LVEF was significantly lower in the H-Adm group than in the L-Adm group (1.9 ±9.7% vs 6.3 ±10.3%, p<0.01). Plasma adrenomedullin concentrations in the early phase of AMI correlate closely with the severity of heart failure, and may offer important prognostic information about the risk of mortality. Our data suggest that plasma adrenomedullin concentrations may be an independent predictor of the deterioration of left-ventricular systolic function.

Angiology, Vol. 56, No. 1, 35-42 (2005)
DOI: 10.1177/000331970505600105


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?